There are several types of muscle dystrophy (MD), each causing different types of progressive weakness and skeletal muscle degeneration. Duchenne muscular dystrophy (DMD) is the most severe form of MD and results in respiratory muscle failure, cardiomyopathy and early death. DMD results from the loss of the protein dystrophin. Using mouse models of MD, Deborah Merrick and colleagues establish a key role for dystrophin in early muscle formation. They demonstrate that dystrophin and caveolin-3 (a dystrophin-associated glycoprotein complex protein) are essential for muscle fiber formation and emergent stem cell function. This work indicates that these protein changes could be early indicators of MD, allowing earlier diagnosis and treatment to enhance the quality of life for MD patients.
Muscular dystrophy traced to prenatal origins
Muscular dystrophy traced to prenatal origins. Dis Model Mech 24 June 2009; 2 (7-8): 313. doi:
Download citation file:
Advertisement
Cited by
New Special Issue: Translating Multiscale Research in Rare Disease. Edited by Monica Justice, Monkol Lek, Karen Liu and Kate Rauen.
This special issue features original Research, Resources & Methods and Review-type articles that aim to interrogate the mechanisms of rare diseases to foster meaningful clinical progress in their diagnosis and treatment.
The role of the International Society for Stem Cell Research (ISSCR) guidelines in disease modelling
The ISSCR provides comprehensive guidelines and standards for using human stem cells in biomedical research. In this Editorial, Cody Juguilon and Joseph Wu discuss how and why these should be incorporated in disease modelling research.
Subject collection: Building advocacy into research
DMM’s series - Building advocacy into research - features interviews, ‘The Patient’s Voice’, with patients and advocates for a range of disease types, with the aim of supporting the highest quality research for the benefit of all patients affected by disease.
Read & Publish Open Access publishing: what authors say
We have had great feedback from authors who have benefitted from our Read & Publish agreement with their institution and have been able to publish Open Access with us without paying an APC. Read what they had to say.
Biologists @ 100 - join us in Liverpool in March 2025
We are excited to invite you to a unique scientific conference, celebrating the 100-year anniversary of The Company of Biologists, and bringing together our different communities. The conference will incorporate the Spring Meetings of the BSCB and the BSDB, the JEB Symposium Sensory Perception in a Changing World and a DMM programme on antimicrobial resistance. Find out more and register your interest to join us in March 2025 in Liverpool, UK.
Other journals from
The Company of Biologists